Search

everythinglearnresearchcommunity

for

Search:↓

O'Tar T. Norwood was a key figure in creating a system to classify male baldness and founding hair restoration societies.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

Dr. Muhammad Ahmad created a simpler system to better describe male pattern hair loss.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Male pattern hair loss is mainly caused by genetics and hormones, especially DHT.

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

No current system perfectly classifies male-pattern hair loss, indicating a need for a new system for better diagnosis and treatment.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

A hybrid model using traditional methods, trichoscopy, and AI improves hair loss assessment.

Certain Prakruti types are more prone to early male pattern baldness.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

MRI helps evaluate androgenetic alopecia severity.

An improved scalp reduction technique reduces the need for hair grafts and has minimal complications.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Epigenetic differences affect hair loss in identical Japanese male twins.

Young men with hair loss may have a higher risk of insulin resistance and related health issues.

Higher sebum levels are linked to more severe male baldness.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

No link found between hair loss severity and PSA levels in men.

The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.

Receding hairlines in men are uneven, with the right side larger than the left.